Jonas: Why CVS, J&J Are Good Buys Now

Oct. 11 (Bloomberg) - -Jeff Jonas, Gabelli & Co. analyst, talks with Bloomberg's Tom Keene about the performance of CVS and Johnson & Johnson. He speaks on Bloomberg Television's "Bloomberg Surveillance."
A Deal With Iran Is More Likely Than Not: Soltvedt
26:55 - Verisk Maplecroft Principal MENA Analyst Torbjorn Soltvedt and Rabobank Senior FX Strategist Jane Foley discuss the Iran nuclear deal and the possibility of lifting sanctions. They speak with Bloomberg’s Anna Edwards on “Countdown.” (Source: Bloomberg)
  • Role of ECB in the Crisis Is Very Crucial: Foley
  • Ace to Buy Chubb for $28.3B
  • JPMorgan: Payrolls to Pave Way for September Rate Hike